Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Dr. med. Daniel Christoph

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Borchert, Sabrina; Mathilakathu, Alexander; Nath, Alina; Wessolly, Michael; Mairinger, Elena; Kreidt, Daniel; Steinborn, Julia; Walter, Robert F. H.; Christoph, Daniel C.; Kollmeier, Jens; Wohlschläger, Jeremias; Mairinger, Thomas; Brcic, Luka; Mairinger, Fabian D.
    Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma : Digital Gene Expression Analysis and Supervised Machine Learning Model
    In: International Journal of Molecular Sciences (IJMS), Jg. 24, 2023, Nr. 15, 12426
    DOI (Open Access)
  • Stahl, Michael; Ertl, Sebastian Willy; Engelmeyer, Pouneh; Heuer, Hans-Christoph; Christoph, Daniel
    Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer : A Matched-Pair Analysis
    In: Oncology Research and Treatment, Jg. 46, 2023, Nr. 3, S. 100 – 104
    DOI
  • Metzenmacher, Martin; Kopp, Hans-Georg; Griesinger, Frank; Reinmuth, Niels; Sebastian, Martin; Serke, Monika; Waller, Cornelius Florian; Thomas, Michael; Eggert, Jochen; Schmid-Bindert, Gerald; Hoiczyk, Mathias; Christoph, Daniel; Kimmich, Martin; Deuß, Burkhard; Seifert, Stephanie; Held, Swantje; Schuler, Martin; Herold, Thomas; Breitenbücher, Frank; Eberhardt, Wilfried
    A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer
    In: Therapeutic Advances in Medical Oncology, Jg. 13, 2021
    DOI, Online Volltext (Open Access)
  • Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Lukas; Umutlu, Lale; Aigner, Clemens; Karl, Kambartel Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang Peter; Herrmann, Ken; Faehling, Martin; Christoph, Daniel
    Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapy
    In: Journal for ImmunoTherapy of Cancer, Jg. 9, 2021, Nr. 3, S. 002262
    DOI, Online Volltext (Open Access)
  • Brcic, Luka; Mathilakathu, Alexander; Walter, Robert F. H.; Wessolly, Michael; Mairinger, Elena; Beckert, Hendrik; Kreidt, Daniel; Steinborn, Julia; Hager, Thomas; Christoph, Daniel; Kollmeier, Jens; Mairinger, Thomas; Wohlschläger, Jeremias; Schmid, Kurt Werner; Borchert, Sabrina; Mairinger, Fabian D.
    Digital gene expression analysis of epithelioid and sarcomatoid mesothelioma reveals differences in immunogenicity
    In: Cancers, Jg. 13, 2021, Nr. 8, S. 1761
    DOI (Open Access)
  • Staehler, Michael; Stöckle, Michael; Christoph, Daniel; Stenzl, Arnulf; Potthoff, Karin; Grimm, Marc-Oliver; Klein, Dunja; Harde, Johanna; Brüning, Fabian; Goebell, Peter J.; Augustin, Marinela; Roos, Frederik; Benz-Rüd, Iris; Marschner, Norbert; Grünwald, Viktor
    Everolimus after failure of one prior VEGF-targeted therapy in metastatic renal cell carcinoma : Final results of the MARC-2 trial
    In: International Journal of Cancer, Jg. 148, 2021, Nr. 7, S. 1685 – 1694
    DOI (Open Access)
  • Mathilakathu, Alexander; Borchert, Sabrina; Wessolly, Michael; Mairinger, Elena; Beckert, Hendrik; Steinborn, Julia; Hager, Thomas; Christoph, Daniel; Kollmeier, Jens; Wohlschläger, Jeremias; Mairinger, Thomas; Schmid, Kurt Werner; Walter, Robert F. H.; Brcic, Luka; Mairinger, Fabian D.
    Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment : A retrospective study
    In: Translational Lung Cancer Research, Jg. 10, 2021, Nr. 7, S. 3030 – 3042
    DOI (Open Access)
  • Metzenmacher, Martin; Rizzo, Filippo; Kambartel, Kato; Panse, Jens; Schaufler, Diana; Scheffler, Matthias; Azeh, Ivo; Hoiczyk, Mathias; Turki, Amin T; Atz, Judith; Buchner, Hannes; Hoffmann, Christopher; Christoph, Daniel
    Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma
    In: Future Oncology, Jg. 17, 2021, Nr. 30, S. 3965 – 3976
    DOI (Open Access)
  • Zeuschner, Philip; Hölters, Sebastian; Stöckle, Michael; Seliger, Barbara; Mueller, Anja; Bachmann, Hagen Sjard; Grünwald, Viktor; Christoph, Daniel; Stenzl, Arnulf; Grimm, Marc-Oliver; Brüning, Fabian; Goebell, Peter J.; Augustin, Marinela; Roos, Frederik; Harde, Johanna; Benz‐rüd, Iris; Staehler, Michael; Junker, Kerstin
    Thrombospondin‐2 and ldh are putative predictive biomarkers for treatment with everolimus in second‐line metastatic clear cell renal cell carcinoma (Marc‐2 study)
    In: Cancers, Jg. 13, 2021, Nr. 11, 2594
    DOI (Open Access)
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Umutlu, Lale; Herrmann, Ken; Christoph, Daniel
    Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant Mesothelioma
    In: Journal of Nuclear Medicine (JNM), Jg. 62, 2021, Nr. 2, S. 191 – 194
    DOI (Open Access)
  • Walter, Robert Fred Henry; Sydow, Saskia Roxanne; Berg, Erika; Kollmeier, Jens; Christoph, Daniel; Christoph, Sandra; Eberhardt, Wilfried; Mairinger, Thomas; Wohlschläger, Jeremias; Schmid, Kurt Werner; Mairinger, Fabian Dominik
    Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma
    In: Cancer Management and Research, Jg. 11, 2019, S. 8711 – 8720
    DOI (Open Access)
  • Borchert, Sabrina; Wessolly, Michael; Schmeller, Jan; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Herold, Thomas; Christoph, Daniel; Walter, Robert F. H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, Kurt Werner; Mairinger, Fabian D.
    Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
    In: BMC Cancer, Jg. 19, 2019, Nr. 1, 108
    DOI (Open Access)
  • Stratmann, Jan A.; Michels, Sebastian; Hornetz, Sofia; Christoph, Daniel C.; Sackmann, Sandra; Spengler, Werner; Bischoff, Helge; Schäfer, Monica; Alt, Jürgen; Müller, Annette; Laack, Eckart; Kimmich, Martin; Griesinger, Frank; Sebastian, Martin
    Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M-positive non-small cell lung cancer
    In: Journal of Cancer Research and Clinical Oncology, Jg. 144, 2018, Nr. 12, S. 2457 – 2463
    DOI
  • Mairinger, Fabian D.; Schmeller, Jan; Borchert, Sabrina; Wessolly, Michael; Mairinger, Elena; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert F.H.; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes
    Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
    In: OncoTarget, Jg. 9, 2018, Nr. 32, S. 22254 – 22268
    DOI (Open Access)
  • Walter, Robert F. H.; Werner, Robert; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Schmeller, Jan; Kollmeier, Jens; Mairinger, Thomas; Hager, Thomas; Bankfalvi, Agnes; Christoph, Daniel; Eberhardt, Wilfried; Plönes, Till; Aigner, Clemens; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian D.
    Inhibition of MDM2 via Nutlin-3A : A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
    In: Journal of Oncology, 2018, 1986982
    DOI (Open Access)
  • Wessolly, Michael; Walter, Robert F. H.; Vollbrecht, Claudia; Werner, Robert; Borchert, Sabrina; Schmeller, Jan; Mairinger, Elena; Herold, Thomas; Streubel, Anna; Christoph, Daniel; Eberhardt, Wilfried E. E.; Kollmeier, Jens; Mairinger, Thomas; Schmid, Kurt W.; Wohlschläger, Jeremias; Hager, Thomas; Mairinger, Fabian D.
    Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine Tumors
    In: Technology in Cancer Research & Treatment (TCRT), Jg. 17, 2018
    DOI (Open Access)
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Worm, Karl; Christoph, Daniel; Wiesweg, Marcel; Freitag, Lutz; Schmid, Kurt Werner; Theegarten, Dirk; Hager, Thomas; Koenig, Michael J.; He, Kai; Taube, Christian; Schuler, Martin; Breitenbücher, Frank
    Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens From Patients With Lung Adenocarcinoma
    In: Clinical Lung Cancer, Jg. 19, 2018, Nr. 6, S. e879 – e884
    DOI
  • Eberhardt, Wilfried; Garassino, M. C.; Rizvi, N. A.; Janne, P. A.; Christoph, Daniel; Peters, S.; Toh, C. K.; Kurata, T.; Costa, E. C.; Koczywas, M.; Felip, E.; Chaft, J.; Qiu, J.; Kowanetz, M.; Coleman, S.; Mocci, S.; Sandler, A.; Gettinger, S.; Johnson, M. L.
    Atezolizumab as 1L therapy for advanced NSCLC in PD-L1-selected patients : updated ORR, PFS and OS data from the BIRCH study
    In: Oncology Research and Treatment, Jg. 40, 2017, Nr. Suppl. 5, S. 220
    DOI
  • Mucha, M. A.; Pöttgen, Christoph; Moliavi, S.; Abu Jawad, Jehad; Gauler, Thomas; Christoph, Daniel; Eberhardt, Wilfried; Stuschke, Martin
    Factors for the long-term Survival of Patients with NSCLC in the Stage of oligometastatic Disease after definitive Local Therapy
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics, Jg. 193, 2017, Nr. Suppl. 1, S. 58
  • Mairinger, Fabian Dominik; Vollbrecht, Claudia; Flom, Elena; Christoph, Daniel; Schmid, Kurt Werner; Kollmeier, Jens; Popper, Helmut Hans; Mairinger, Thomas; Walter, Robert Fred Henry
    Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
    In: OncoTarget, Jg. 8, 2017, Nr. 23, S. 37502 – 37510
    DOI (Open Access)
  • Welter, Stefan; Arfanis, Elias; Christoph, Daniel; Hager, Thomas; Roesel, Christian; Aigner, Clemens; Weinreich, Gerhard; Theegarten, Dirk
    Growth patterns of pulmonary metastases : Should we adjust resection techniques to primary histology and size?
    In: European Journal of Cardio-Thoracic Surgery, Jg. 52, 2017, Nr. 1, S. 39 – 46
    DOI
  • Wiesweg, Marcel; Eberhardt, Wilfried; Reis, Henning; Ting, Saskia; Savvidou, Nikoleta; Skiba, Charlotte; Herold, Thomas; Christoph, Daniel; Meiler, Johannes; Worm, Karl; Kasper, Stefan; Theegarten, Dirk; Hense, Jörg; Hager, Thomas; Darwiche, Kaid; Oezkan, Filiz; Aigner, Clemens; Welter, Stefan; Kühl, Hilmar; Stuschke, Martin; Schmid, Kurt Werner; Schuler, Martin
    High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer
    In: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. 1, S. 54 – 64
    DOI (Open Access)
  • Peters, Solange; Gettinger, Scott; Johnson, Melissa L.; Jänne, Pasi A.; Garassino, Marina C.; Christoph, Daniel; Toh, Chee Keong; Rizvi, Naiyer A.; Chaft, Jamie E.; Costa, Enric Carcereny; Patel, Jyoti D.; Chow, Laura Q.M.; Koczywas, Marianna; Ho, Cheryl; Früh, Martin; Van Den Heuvel, Michel; Rothenstein, Jeffrey; Reck, Martin; Paz-Ares, Luis; Shepherd, Frances A.; Kurata, Takayasu; Li, Zhengrong; Qiu, Jiaheng; Kowanetz, Marcin; Mocci, Simonetta; Shankar, Geetha; Sandler, Alan; Felip, Enriqueta
    Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH)
    In: Journal of Clinical Oncology (JCO), Jg. 35, 2017, Nr. 24, S. 2781 – 2789
    DOI, Online Volltext (Open Access)
  • Oezkan, Filiz; Herold, Thomas; Darwiche, Kaid; Eberhardt, Wilfried; Christoph, Daniel; Worm, Karl; Freitag, Lutz; Schmid, Kurt Werner; Hager, Thomas; Breitenbücher, Frank; Schuler, Martin
    Rapid and Highly Sensitive EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA Specimen of Lung Adenocarcinoma
    In: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. Suppl. 1, S. S1201 – S1201
  • Mairinger, Fabian Dominik; Werner, Robert; Flom, Elena; Schmeller, Jan; Borchert, Sabrina; Wessolly, Michael; Wohlschläger, Jeremias; Hager, Thomas; Mairinger, Thomas; Kollmeier, Jens; Christoph, Daniel; Schmid, Kurt Werner; Walter, Robert Fred Henry
    miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma
    In: Virchows Archiv, Jg. 470, 2017, Nr. 6, S. 627 – 637
    DOI
  • Walter, Robert Fred Henry; Werner, Robert; Vollbrecht, Claudia; Hager, Thomas; Flom, Elena; Christoph, Daniel; Schmeller, Jan; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian Dominik
    ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology
    In: PLoS ONE, Jg. 11, 2016, Nr. 11, S. e0165181
    DOI (Open Access)
  • Fennell, D A; Summers, Y; Cadranel, J; Benepal, T; Christoph, Daniel; Lal, R; Das, M; Maxwell, F; Visseren-Grul, C; Ferry, D
    Cisplatin in the modern era : The backbone of first-line chemotherapy for non-small cell lung cancer
    In: Cancer Treatment Reviews, Jg. 44, 2016, S. 42 – 50
    DOI
  • Metzenmacher, Martin; Christoph, Daniel
    Efficacy and safety of nivolumab combined with standard therapies for first-line therapy of advanced non-small cell lung cancer
    In: Journal of Thoracic Disease, Jg. 8, 2016, Nr. 10, S. E1254 – E1256
    DOI (Open Access)
  • Walter, Robert Fred Henry; Mairinger, Fabian Dominik; Werner, Robert; Vollbrecht, Claudia; Hager, Thomas; Schmid, Kurt Werner; Wohlschläger, Jeremias; Christoph, Daniel
    Folic-acid metabolism and DNA-repair phenotypes differ between neuroendocrine lung tumors and associate with aggressive subtypes, therapy resistance and outcome
    In: OncoTarget, Jg. 7, 2016, Nr. 15, S. 20166 – 20179
    DOI (Open Access)
  • Walter, Robert Fred Henry; Vollbrecht, Claudia; Christoph, Daniel; Werner, Robert; Schmeller, Jan; Flom, Elena; Trakada, Georgia; Rapti, Aggeliki; Adamidis, Vasilis; Hohenforst-Schmidt, Wolfgang; Kollmeier, Jens; Mairinger, Thomas; Wohlschläger, Jeremias; Zarogoulidis, Paul; Porpodis, Konstantinos; Schmidt, Kurt Werner; Mairinger, Fabian Dominik
    Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors
    In: Journal of Cancer, Jg. 7, 2016, Nr. 15, S. 2165 – 2172
    DOI, Online Volltext (Open Access)
  • Özkan, Filiz; Khan, Amir Maqbul; Hager, Thomas; Freitag, Lutz; Christoph, Daniel; Darwiche, Kaid
    OSNA : a fast molecular test based on CK19 mRNA concentration for assessment of EBUS-TBNA samples in lung cancer patients
    In: Clinical Lung Cancer, Jg. 17, 2016, Nr. 3, S. 198 – 204
    DOI
  • Wakelee, Heather; Patel, Jyoti D; Heist, Rebecca; Balmanoukian, Ani; Besse, Benjamin; Felip, Enriqueta; Carcereny Costa, Enric; Chow, Laura Q; Koczywas, Marianna; Garassino, Marina C; Christoph, Daniel; Toh, Chee Keong; Johnson, Melissa L; Chaft, Jamie; Kurata, Takayasu; Qiu, Jiaheng; Kowanetz, Marcin; Coleman, Shelley; Mocci, Simonetta; Sandler, Alan; Gettinger, Scott N; Peters, Solange
    Phase II Trial of Atezolizumab for Patients with PD-L1-Selected Advanced NSCLC (BIRCH) : Updated Efficacy and Exploratory Biomarker Results: Topic: Medical Oncology
    In: Journal of Thoracic Oncology, Jg. 11, 2016, Nr. Supplement 11, S. 251 – S.252
    DOI (Open Access)
  • Walter, Robert Fred Henry; Vollbrecht, Claudia; Werner, Robert; Mairinger, Thomas; Schmeller, Jan; Flom, Elena; Wohlschläger, Jeremias; Barbetakis, Nikolaos; Paliouras, Dimitrios; Chatzinikolaou, Fotios; Adamidis, Vasilis; Tsakiridis, Kosmas; Zarogoulidis, Paul; Trakada, Georgia; Christoph, Daniel; Schmid, Kurt Werner; Mairinger, Fabian Dominik
    Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy
    In: Journal of Cancer, Jg. 7, 2016, Nr. 13, S. 1915 – 1925
    DOI, Online Volltext (Open Access)
  • Walter, Robert Fred Henry; Vollbrecht, Claudia; Werner, Robert; Wohlschläger, Jeremias; Christoph, Daniel; Schmid, Kurt Werner; Mairinger, Fabian Dominik
    microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma
    In: OncoTarget, Jg. 7, 2016, Nr. 14, S. 18713 – 18721
    DOI
  • Reis, Henning; Herold, Thomas; Ting, S.; Worm, Karl Heinz; Huber, U.; Christoph, Daniel; Eberhardt, Wilfried; Kostbade, K.; Kasper, Stefan; Stamatis, Georgios; Welter, Stefan; Darwiche, Kaid; Karpf-Wissel, Rüdiger; Theegarten, Dirk; Schmidt, K. W.; Schuler, Martin; Wiesweg, Marcel
    HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas
    In: Lung Cancer, Jg. 88, 2015, Nr. 1, S. 34 – 41
    DOI
  • Walter, Robert Fred Henry; Werner, Robert; Ting, Saskia; Vollbrecht, Claudia; Theegarten, Dirk; Christoph, Daniel; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian Dominik
    Identification of deregulation of apoptosis and cell cycle in neuroendocrine tumors of the lung via NanoString nCounter expression analysis
    In: OncoTarget, Jg. 6, 2015, Nr. 28, S. 24690 – 24698
    DOI (Open Access)
  • Walter, R F H; Mairinger, F D; Ting, Saskia; Vollbrecht, C; Mairinger, T; Theegarten, Dirk; Christoph, Daniel; Schmid, Kurt Werner; Wohlschläger, Jeremias
    MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53
    In: British Journal of Cancer (BJC), Jg. 112, 2015, Nr. 5, S. 883 – 890
    DOI (Open Access)
  • Vollbrecht, Claudia; Werner, Robert J.; Walter, Robert Fred Henry; Christoph, Daniel; Heukamp, Lukas Carl Arl; Peifer, Martin; Hirsch, Burkhard; Burbat, Lina; Mairinger, Thomas; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, Fabian Dominik
    Mutational analysis of pulmonary tumours with neuroendocrine features using targeted massive parallel sequencing: a comparison of a neglected tumour group
    In: British Journal of Cancer (BJC), Jg. 113, 2015, Nr. 12, S. 1704 – 1711
    DOI (Open Access)
  • Walter, Robert Fred Henry; Mairinger, Fabian Dominik; Werner, Robert; Ting, Saskia; Vollbrecht, Claudia; Theegarten, Dirk; Christoph, Daniel; Zarogoulidis, Konstantinos; Schmid, Kurt Werner; Zarogoulidis, Paul; Wohlschläger, Jeremias
    SOX4, SOX11 and PAX6 mRNA expression was identified as a (prognostic) marker for the aggressiveness of neuroendocrine tumors of the lung by using next-generation expression analysis (NanoString)
    In: Future Oncology, Jg. 11, 2015, Nr. 7, S. 1027 – 1036
    DOI
  • Mairinger, Fabian D.; Walter, Robert F. H.; Werner, Robert; Christoph, Daniel; Ting, Saskia; Vollbrecht, Claudia; Zarogoulidis, Konstantinos; Huang, Haidong; Li, Qiang; Schmid, Kurt Werner; Wohlschläger, Jeremias; Zarogoulidis, Paul
    Activation of angiogenesis differs strongly between pulmonary carcinoids and neuroendocrine carinomas and is crucial for carcinoid tumourgenesis
    In: Journal of Cancer, Jg. 5, 2014, Nr. 6, S. 465 – 471
    DOI (Open Access)
  • Mairinger, Fabian Dominik; Ting, Saskia; Werner, Robert; Walter, Robert Fred Henry; Hager, Thomas; Vollbrecht, Claudia; Christoph, Daniel; Worm, Karl; Mairinger, Thomas; Sheu-Grabellus, Sien-Yi; Theegarten, Dirk; Schmid, Kurt Werner; Wohlschläger, Jeremias
    Different micro-RNA expression profiles distinguish subtypes of neuroendocrine tumors of the lung : results of a profiling study
    In: Modern Pathology, Jg. 27, 2014, Nr. 12, S. 1632 – 1640
    DOI
  • Nensa, Felix; Stattaus, Jörg; Morgan, Bruno; Horsfield, Mark A.; Soria, Jean-Charles; Besse, Benjamin; Gounant, Valerie; Khalil, Antoine; Seng, Katja; Fischer, Berthold; Krissel, Heiko; Laurent, Dirk; Christoph, Daniel; Eberhardt, Wilfried; Gauler, Thomas
    Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancer
    In: Future Oncology, Jg. 10, 2014, Nr. 5, S. 823 – 833
    DOI
  • Mairinger, Fabian Dominik; Walter, Robert Fred Henry; Theegarten, Dirk; Hager, Thomas; Vollbrecht, Claudia; Christoph, Daniel; Worm, Karl; Ting, Saskia; Werner, Robert; Stamatis, Georgios; Mairinger, Thomas; Baba, Hideo Andreas; Zarogoulidis, Konstantinos; Huang, Haidong; Li, Qiang; Tsakiridis, Kosmas; Zarogoulidis, Paul; Schmid, Kurt Werner; Wohlschläger, Jeremias
    Gene expression analysis of the 26S proteasome subunit PSMB4 reveals significant upregulation, different expression and association with proliferation in human pulmonary neuroendocrine tumours
    In: Journal of Cancer, Jg. 5, 2014, Nr. 8, S. 646 – 654
    DOI (Open Access)
  • Mairinger, Fabian D.; Walter, Robert F. H.; Ting, Saskia; Vollbrecht, Claudia; Kollmeier, Jens; Griff, Sergei; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Theegarten, Dirk; Schmid, Kurt Werner; Wohlschläger, Jeremias
    Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma
    In: Future Oncology, Jg. 10, 2014, Nr. 6, S. 995 – 1005
    DOI
  • Darwiche, Kaid; Ozkan, F; Ting, Saskia; Johnen, G; Brüning, T; Soltermann, A; Huber, L C; Christoph, Daniel; Freitag, Lutz; Franzen, D
    Prätherapeutische Biomarker des Lungenkarzinoms unter besonderer Berücksichtigung der Bronchoskopie
    In: Pneumologie, Jg. 68, 2014, Nr. 11, S. 719 – 726
    DOI
  • Christoph, Daniel; Eberhardt, Wilfried
    Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements
    In: Current Opinion in Oncology, Jg. 26, 2014, Nr. 2, S. 171 – 181
    DOI
  • Ting, Saskia; Mairinger, Fabian D.; Hager, Thomas; Welter, Stefan; Eberhardt, Wilfried; Wohlschläger, Jeremias; Schmid, Kurt Werner; Christoph, Daniel
    ERCC1, MLH1, MSH2, MSH6, and βiII-tubulin: Resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma
    In: Clinical Lung Cancer, Jg. 14, 2013, Nr. 5, S. 558 – 567
    DOI
  • Welter, Stefan; Schwan, Alexandra; Cheufou, Danjouma; Darwiche, Kaid; Christoph, Daniel; Eberhardt, Wilfried; Weinreich, Gerhard; Stamatis, Georgios
    Midterm changes in quality of life : A prospective evaluation after open pulmonary metastasectomy
    In: The Annals of Thoracic Surgery, Jg. 95, 2013, Nr. 3, S. 1006 – 1011
    DOI
  • Gauler, Thomas Christoph; Christoph, Daniel Christian; Fischer, Juergen; Frickhofen, Norbert; Huber, Rudolf; Gonschorek, Christine; Roth, Katrin; Giurescu, Marius; Eberhardt, Wilfried Ernst Erich
    Phase-I study of sagopilone in combination with cisplatin in chemotherapy-naive patients with metastasised small-cell lung cancer
    In: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 11, S. 2461 – 2468
    DOI
  • Christoph, Daniel; Reyna-Asuncion, Bernadette; Hassan, Biftu; Tran, Cindy; Maltzman, Julia D.; O'Shannessy, Daniel J.; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Hoiczyk, M.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Significance of folate receptor alpha and thymidylate synthase protein expression in patients with non-small-cell lung cancer treated with pemetrexed
    In: Journal of Thoracic Oncology, Jg. 8, 2013, Nr. 1, S. 19 – 30
    DOI
  • Christoph, Daniel; Hoffmann, Andreas-Claudius; Gauler, Thomas; Asuncion, Bernadette Reyna; Loewendick, Heike; Peglow, Anja; Hassan, Biftu; Tran, Cindy; Wynes, Murry W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 4, S. 766 – 767
    DOI (Open Access)
  • Drescher, O.; Eberhardt, Wilfried; Prittwitz, R.; Gkika, E.; Korfee, Sönke; Theegarten, Dirk; Welter, Stefan; Krbek, T.; Stamatis, Georgios; Pöttgen, Christoph; Schuler, Martin; Christoph, Daniel
    Distribution pattern of metastases and their associations with survival of malignant pleural mesothelioma patients undergoing different treatment modalities
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 140
  • Christoph, Daniel; Asuncion, Bernadette Reyna; Mascaux, Celine; Tran, Cindy; Lu, Xian; Wynes, Murry W.; Gauler, Thomas; Wohlschläger, Jeremias; Theegarten, Dirk; Neumann, Volker; Hepp, Rodrigo; Welter, Stefan; Stamatis, Georgios; Tannapfel, Andrea; Schuler, Martin; Eberhardt, Wilfried; Hirsch, Fred R.
    Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, S. 1440 – 1448
    DOI (Open Access)
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Investigation of Folate Receptor alpha and Thymidylate Synthase Proteins Expression in metastatic Non-Small Cell Lung Cancer Patients treated with Pemetrexed-based Chemotherapy
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 9, Suppl. 4, S. S211 – S212
  • Christoph, Daniel; Asuncion, B. R.; Hassan, B.; Maltzman, J.; O'Shannessy, D.; Gauler, Thomas; Wohlschläger, Jeremias; Wynes, M. W.; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Significance of Folate Receptor alpha (FRA) and Thymidylate Synthase (TS) expression in metastatic non-small cell lung cancer patients treated with pemetrexed-based chemotherapy
    In: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 34
  • Wynes, M. W.; Konopa, K.; Singh, S.; Reyna-Asuncion, B.; Ranger-Moore, J.; Sternau, A.; Christoph, Daniel; Dziadziuszko, R.; Jassem, J.; Hirsch, F. R.
    Thymidylate Synthase Protein Expression by IHC and Gene Copy Number by SISH Correlate and Show Great Variability in Non–Small Cell Lung Cancer
    In: Journal of Thoracic Oncology, Jg. 7, 2012, Nr. 6, S. 982 – 992
    DOI, Online Volltext (Open Access)
  • Christoph, Daniel; Kasper, Stefan; Gauler, Thomas; Loesch, Christian; Engelhard, Marianne; Theegarten, Dirk; Pöttgen, Christoph; Hepp, Rodrigo; Peglow, Anja; Loewendick, Heike; Welter, Stefan; Stamatis, Georgios; Hirsch, Fred R.; Schuler, Martin; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Βv-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer
    In: British Journal of Cancer (BJC), Jg. 107, 2012, Nr. 5, S. 823 – 830
    DOI (Open Access)
  • Pöttgen, Christoph; Le Pechoux, C.; Gauler, Thomas; Stuschke, Martin; Grunenwald, D. H.; Stamatis, Georgios; Bildat, Stephan; Krbek, T.; Christoph, Daniel; Welter, Stefan; Fischer, B.; Hepp, R.; Theegarten, Dirk; Eberhardt, Wilfried
    10-year long-term survival (LTS) of induction (IND) chemotherapy (CTX) with three cycles cisplatin(P)/paclitaxel(T) followed by concurrent (CC) chemoradiation (CTX/RTX) P/Etoposide (ETO)/45 GY (1.5 GY BID) plus surgery (S) - A multicenter phase-II trial (Cistaxol)
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 494
  • Christoph, Daniel; Gauler, Thomas; Engelhard, M.; Theegarten, Dirk; Pöttgen, Christoph; Hepp, R.; Schuler, Martin; Hirsch, F.; Eberhardt, Wilfried; Wohlschläger, Jeremias
    Evaluation of betaV-tubulin expression as novel predictive biomarker for clinical benefit from treatment with taxanes in non-small cell lung cancer (NSCLC)
    In: European Journal of Cancer (EJC), Jg. 47, 2011, Nr. Suppl. 4, S. 14
  • Gauler, Thomas; Pöttgen, Christoph; Korfee, Sönke; Wagner, H.; Hepp, R.; Stamatis, Georgios; Christoph, Daniel; Passlick, B.; Budach, V.; Seeber, S.; Wilke, Hansjochen; Stuschke, Martin; Eberhardt, Wilfried
    Long-term survival (LTS) and competing risks within a prospective multicenter german randomized trial comparing induction (IND) chemotherapy (CTX) followed by concurrent (CC) chemoradiation (CTX/RTX) plus surgery (S) (= Trimodality) supplemented by PCI VE
    In: Journal of Thoracic Oncology, Jg. 6, 2011, Nr. 6, Suppl. 2, S. 495
  • Christoph, Daniel; Schuler, Martin
    Polo-like kinase 1 inhibitors in mono- and combination therapies : A new strategy for treating malignancies
    In: Expert Review of Anticancer Therapy, Jg. 11, 2011, Nr. 7, S. 1117 – 1132
    DOI
  • Christoph, Daniel; Mascaux, C.; Wynes, M. W.; Reyna Asuncion, B.; Wohlschläger, Jeremias; Theegarten, Dirk; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried; Hirsch, F. R.
    Predictive value of thymidylate synthase and folylpoly-glutamate synthetase for clinical benefit from pemetrexed in malignant pleural mesothelioma
    In: Journal of Clinical Oncology (JCO), Jg. 29, 2011, Nr. 15_suppl, S. 7024
    DOI
  • Christoph, Daniel; Wittkowski, Lukas; Stattaus, Jörg; Pöttgen, Christoph; Keyvani, Kathy; Gauler, Thomas; Schuler, Martin; Eberhardt, Wilfried
    Very Late and Isolated Leptomeningeal Relapse of a Pulmonary Adenocarcinoma Presenting as Dementia
    In: Onkologie, Jg. 34, 2011, Nr. 6, S. 316 – 320
    DOI
  • Christoph, Daniel; Böse, Dirk; Johnson, Kristian T. M.; Schlosser, Thomas Wilfried; Hunold, Peter; Baba, Hideo Andreas; Erbel, Raimund; Philipp, Sebastian
    Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from val30met mutation with no clinical signs of polyneuropathy
    In: Circulation: Heart Failure, Jg. 2, 2009, Nr. 5, S. 512 – 515
    DOI (Open Access)

    • Vorworte / Nachworte

  • Christoph, Daniel; Reckamp, K. L.
    Intraventricular Chemotherapy for Leptomeningeal Carcinomatosis from Lung Cancer : A Feasible and Beneficial Treatment Option?
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 8, 2013, Nr. 5, S. 523 – 524
    DOI

    • Abstracts

  • Stuschke, Martin; Passlick, B.; Groeschel, A.; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jaenicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Thomas, M.; Eberhardt, Wilfried
    Clinical Platform for Research into molecular Testing, Treatment and Disease Progression in Patients with Lung Cancer (CRISP) : First Real-World Evidence on Stage II and III NSCLC in Germany - AIO-TRK-0315
    In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 197, 2021, Nr. Suppl. 1, S. S11 – S12
  • Gröschel, A.; Passlick, B.; Stuschke, Martin; Christopoulos, P.; Reck, M.; Grah, C.; Groth, A.; Hipper, A.; Chiabudini, M.; Fleitz, A.; Jänicke, M.; Spring, L.; Christoph, Daniel; Bernhardt, C.; Reiser, M.; Zahn, M-O.; Sebastian, M.; Griesinger, F.; Thomas, M.; Eberhardt, Wilfried
    Clinical research platform into molecular testing, treatment and outcome of non-small cell lung carcinoma patients (CRISP) : First real-world evidence of NSCLC stage II and III in Germany - AIO-TRK-0315
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. S935 – S936
    DOI (Open Access)
  • Christoph, Daniel; Ferdinandus, Justin; Metzenmacher, Martin; Kessler, Peter; Umutlu, Lale; Aigner, Clemens; Kambartel, Karl-Otto; Grünwald, Viktor; Eberhardt, Wilfried; Fendler, Wolfgang; Herrmann, Ken; Faehling, Martin
    Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapy
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 39, 2021, Nr. 15_Suppl, S. 9050 – 9050
    DOI (Open Access)
  • Christoph, Daniel; Rizzo, Francesca; Kambartel, K-O.; Winke, S.; Panse, J.; Abdulla, Diana; Scheffler, Michael; Azeh, I.T.; Hoiczyk, Mathias; Turki, A.; Metzenmacher, Martin
    Docetaxel/nindetanib as efficient treatment option after failure of immune checkpoint inhibition : Real-world evidence
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, S. 876
    DOI (Open Access)
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging, July 11-14, 2020, Virtual,
    In: Journal of Nuclear Medicine (JNM). New York: Springer, Jg. 61, 2020, Nr. Suppl. 1, 243
    Online Volltext (Open Access)
  • Ferdinandus, Justin; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Christoph, Daniel
    PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
    EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 47, 2020, Nr. Supplement 1, S. S353
    DOI (Open Access)
  • Christoph, Daniel; Barbato, Francesco; Chodyla, Michal; Fendler, Wolfgang P.; Kessler, Lukas; Pomykala, Kelsey L.; Metzenmacher, Martin; Krefting, Frederik; Hager, Thomas; Herrmann, Ken; Ferdinandus, Justin
    Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
    ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 31, 2020, Nr. Suppl. 4, S. S1076 – S1077
    DOI (Open Access)
  • Borchert, S.; Wessolly, M.; Schmeller, J.; Mairinger, E.; Kollmeier, J.; Hager, T.; Mairinger, T.; Herold, T.; Christoph, Daniel; Walter, R.; Eberhardt, Wilfried; Plönes, T.; Wohlschläger, Jeremias; Aigner, Clemens; Schmid, K.; Mairinger, F.
    Defects in Homologous Recombination Repair Indicates Susceptibility for Olaparib Treatment in Malignant Pleural Mesothelioma
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 14, 2019, Nr. 10, Supplement, S. S482
    DOI (Open Access)
  • Schmeller, Jan; Mairinger, Fabian; Wessolly, Michael; Mairinger, Elena; Borchert, Sabrina; Kollmeier, Jens; Hager, Thomas; Mairinger, Thomas; Christoph, Daniel; Walter, Robert; Eberhardt, Wilfried; Plönes, Till; Wohlschläger, Jeremias; Jasani, Bharat; Schmid, Kurt Werner; Bankfalvi, Agnes
    Immunohistochemically Detectable Metallothionein Expression in Malignant Pleural Mesotheliomas is Strongly Associated with Early Failure to Platin-Based Chemotherapy
    Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,
    In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 110 – 111
    DOI
  • Plones, T.; Schmeller, J.; Christoph, Daniel; Walter, R.; Hager, T.; Schmid, Kurt Werner; Borchert, S.; Bankfalvi, Agnes; Mairinger, T.; Mairinger, E.; Mairinger, F.; Wohlschlager, J.; Eberhardt, Wilfried; Wessolly, M.; Kollmeier
    Processing Escapes : an Alternative Explanation for Immune Therapy Resistance
    Herbsttagung der Sektion Zellbiologie in der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V., Essen, 09.–10.11.2018,
    In: Pneumologie. Stuttgart: Thieme, Jg. 73, 2019, Nr. 02, S. 111 – 112
    DOI
  • Borchert, S.; Mairinger, E.; Schmeller, J.; Wessolly, M.; Hager, T.; Bankfalvi, Agnes; Plönes, T.; Kollmeier, J.; Christoph, Daniel; Wohlschläger, Jeremias; Mairinger, T.; Schmid, Kurt Werner; Walter, R.; Mairinger, F.
    BRCAness phenotype is common in MPM and is associated with response to olaparib in vitro
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 175
    DOI (Open Access)
  • Mairinger, F.; Schmeller, J.; Wessolly, M.; Mairinger, E.; Borchert, S.; Kollmeier, J.; Hager, T.; Mairinger, T.; Christoph, Daniel; Walter, R.; Plönes, T.; Wohlschläger, Jeremias; Jasani, B.; Schmid, Kurt Werner; Bankfalvi, Agnes
    Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 115
    DOI (Open Access)
  • Walter, R.; Werner, R.; Schmeller, J.; Wessolly, M.; Mairinger, E.; Borchert, S.; Kollmeier, J.; Mairinger, T.; Hager, T.; Bankfalvi, Agnes; Christoph, Daniel; Plönes, T.; Schmid, Kurt Werner; Wohlschläger, Jeremias; Mairinger, F.
    Inhibition of MDM2 via Nutlin-3A : A potential therapeutic approach for pleural mesotheliomas with MDM2-induced inactivation of P53
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 175
    DOI (Open Access)
  • Nadjm, S.; Exner, J. P.; Gauler, Thomas; Pöttgen, Christoph; Darwiche, Kaid; Cheufou, D.; Krebs, B.; Metzenmacher, M.; Oezkan, F.; Rebmann, Vera; Umutlu, Lale; Deuschl, C.; Li, Y.; Lahner, Harald; Christoph, Daniel; Hoiczyk, M.; Witzke, Oliver; Hoffmann, Andreas-Claudius; Aigner, Clemens; Theegarten, Dirk; Taube, Christian; Schuler, Martin; Stamatis, Georgios; Stuschke, Martin; Eberhardt, Wilfried
    Long-term Survival(LTS) and Survivorship Program(SS-P) of Lung Cancer(LC) Patients(Pts). Investigations(Invest) on LT-toxicities(Tox) and late morbidities(Morb)
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 108
    DOI (Open Access)
  • Mairinger, F.; Meier, S.; Wessolly, M.; Köhler, C.; Wagner, F.; Mairinger, E.; Schmeller, J.; Borchert, S.; Wohlschläger, Jeremias; Plönes, T.; Hager, T.; Rozynek, P.; Kollmeier, J.; Christoph, Daniel; Schmid, Kurt Werner; Mairinger, T.; Johnen, G.; Walter, R.
    Mass Spectrometry based Methylation Analysis of MDM2, CDKN2A, RB1, TP53 and TP73 and Associations to MDM2 Overexpression in Malignant Pleural mesothelioma
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 115
    DOI (Open Access)
  • Wessolly, M.; Borchert, S.; Mairinger, E.; Schmeller, J.; Walter, R.; Hager, T.; Bankfalvi, Agnes; Plönes, T.; Christoph, Daniel; Kollmeier, J.; Mairinger, T.; Wohlschläger, Jeremias; Schmid, Kurt Werner; Mairinger, F.
    Processing escape mechanisms through alterated proteasomal cleavage of epitopes affects immune response in pulmonary neuroendocrine tumors
    33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 176
    DOI (Open Access)
  • Walter, R.; Werner, R.; Ting, Saskia; Vollbrecht, C.; Kollmeier, J.; Griff, S.; Christoph, Daniel; Wohlschläger, Jeremias; Schmid, Kurt Werner; Mairinger, F.
    Identification of prognostic and predictive biomarkers in malignant pleural mesothelioma in 134 patients from two research sites (Berlin and Essen)
    Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 39, 2016, Nr. Suppl. 1, S. 123
    DOI
  • Eberhardt, Wilfried; Hepp, R.; Gauler, Thomas; Christoph, Daniel; Hoffmann, Andreas-Claudius; Theegarten, Dirk; Welter, Stefan; Schmid, Kurt Werner; Wohlschläger, Jeremias; Passlick, B.; Le Pechoux, C.; Stamatis, Georgios; Stuschke, Martin; Pöttgen, Christoph
    Competing risks analysis and long-term survival (LTS) of patients (PTS) with locally advanced (LAD) stage III non-small- cell lung cancer (NSCLC) treated on sequential trimodality (TM) trials
    14th World Conference on Lung Cancer (WCLC), July 03 - 07, 2011, Amsterdam, The Netherlands,
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 6, 2011, Nr. 6, Suppl. 2, S. S376 – S377
  • Wynes, M. W.; Dziadziuszko, R.; Singh, S.; Christoph, Daniel; Ranger-Moore, J.; Szostakiewicz, B.; Dziadziuszko, K.; Eberhardt, Wilfried; Jassem, J.; Hirsch, F. R.
    Increased Thymidylate Synthase (TS) Gene Copy Number in NSCLC
    In: Journal of Thoracic Oncology. Amsterdam: Elsevier, Jg. 5, 2010, Nr. 5 Suppl. 1, S. S56
    DOI

    • Bücher/Sammelwerke/Tagungsbände

  • Christoph, Daniel
    Prädiktive Biomarker für Platin- und Pemetrexed-basierte Chemotherapien bei malignen pulmonalen und pleuralen Tumoren
    Duisburg ; Essen, 2017

    • Poster / Posterbeiträge

  • Christoph, Daniel; Metzenmacher, Martin; Bölükbas, S.; Volmerig, J.; Nilius, G.; Moka, Detlef; Hautzel, Hubertus
    PET-CT detects response to treatment with ipilimumab and nivolumab in malignant mesothelioma far better than CT
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 226 – 227
    DOI (Open Access)
  • Christoph, Daniel C. C.; Metzenmacher, M.; Bölükbas, S.; Volmerig, J.; Nilius, G.; Moka, Detlef; Hautzel, H.
    PET-CT detects response to treatment with ipilimumab and nivolumab in malignant mesothelioma far better than CT
    ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 34, 2023, Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S1135
    DOI (Open Access)
  • Reitnauer, L.; Evers, G.; Christoph, Daniel; Wiesweg, Marcel; Glanemann, Franziska; Webendörfer, Maximilian P.; Bleckmann, A.; et al.
    Relapse after radiochemotherapy and consolidative Durvalumab in Stage III NSCLC – a retrospective analysis in a real-world setting
    Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 13. bis 16. Oktober 2023, Hamburg, Germany,
    In: Oncology Research and Treatment. Basel: Karger, Jg. 46, 2023, Nr. Supplement 5: DGHO Abstracts, S. 229
    DOI (Open Access)